Navigation Links
Statement From the Lupus Foundation of America Regarding the Release of Top-Line Results From a Study of Rituxan for the Treatment of Lupus
Date:4/29/2008

WASHINGTON, April 29 /PRNewswire-USNewswire/ -- Preliminary results were released today from a late-stage clinical trial of Rituxan (rituximab) for the treatment of lupus. The study did not meet its primary or secondary endpoints of clinically reducing the severity of SLE (systemic lupus erythematosus) in people with moderate disease.

The findings are initial results from a Phase II/III study conducted by Genentech, Inc., known as the EXPLORER study. Rituxan is approved by the U.S. Food and Drug Administration for the treatment of non-Hodgkin's lymphoma, and was more recently approved, in combination with methotrexate, to treat rheumatoid arthritis. More detailed findings from the trial are expected to be presented at a medical conference this fall.

Following is a statement about the study results from Sandra C. Raymond, President & CEO of the Lupus Foundation of America:

"Demonstrating the impact of a treatment in a lupus clinical trial can be difficult, as lupus manifests itself differently in different people, and can increase and decrease in severity from one day to another. So while these new results are disappointing, they are not necessarily surprising.

"People with lupus have been waiting for a new treatment for nearly 45 years while suffering from this disabling and sometimes life-threatening disease. But it's important to remember that there are a variety of promising therapies in the near-term pipeline - including an ongoing study of Rituxan for the treatment of lupus nephritis (kidney disease). That study assesses Rituxan's potential in a focused subset of lupus patients with a highly objective outcome. Thus, we remain optimistic that we are coming ever closer to new and better treatments for lupus.

"Lupus patients have suffered without a new treatment for more than four decades. For this reason, we are grateful to the companies that are searching for new lupus treatments. The millions of people who bat
'/>"/>

SOURCE Lupus Foundation of America
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Ortho Biotech Statement on U.S. Food and Drug Administration Oncologic Drugs Advisory Committee Vote
2. Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
3. Media Statement: MHA Keystone Center for Patient Safety & Quality OHRP Ruling
4. Statement from the American Diabetes Association Related to ACCORD Trial Announcement
5. Statement of Andrea Kavanagh, Director, Pure Salmon Campaign, on the Science Sea Lice Study
6. AIDS Action Council Statement on World AIDS Day 2007: Leadership Needed for a National Strategy to Stop the AIDS Epidemic
7. Statement by US Oncology on FDA Label on Erythropoiesis Stimulating Agents (ESAs)
8. Statement From The National Conclave on HIV/AIDS Policy for Black Clergy
9. Statement by KCP Chairman Dr. Edward Jones in Response to FDA Advisory Committee on Benefits and Risks of Erythropoietin-Stimulating Agents in Treatment of Kidney Patients
10. Rigels R788 Slows Progression of Murine Lupus in Preclinical Studies
11. Steps Toward Stopping Autoimmune Disease: International Consortium Identifies Genes Linked to Lupus

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)..., ROTTERDAM, The Netherlands, December 3 /PR...ny focused on the discovery and development of hum...y(TM) platform, today,announced the successful sec.... The Company raised an additional EUR 3.0 million...investors, Credit Agricole Private Equity and,VIB ...
(Date:12/2/2009)... NEW YORK, Dec. 2 Reportlinker.co...vailable in its catalogue: ,, Hospital Informa...mp; Opportunities ,, http://www.reportlinker....al-Update-of-Market-Trends--Opportunities.html ,...rons on the benefits of using Information Technolo...
(Date:12/2/2009)... NEW YORK, Dec. 2 Reportlinker.com...ailable in its catalogue: ,, EEG/EMG/Brain Fu...http://www.reportlinker.com/p0164319/EEG/EMG/Brain...,, Steep rise in obesity, cardiovascular, and a...cephalograph (EEG) diagnostic and monitoring equip...
Breaking Medicine Technology:arGEN-X Concludes EUR 12.5 Million Series A Financing Round 2arGEN-X Concludes EUR 12.5 Million Series A Financing Round 3arGEN-X Concludes EUR 12.5 Million Series A Financing Round 4Reportlinker Adds Hospital Information Systems - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Hospital Information Systems - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Hospital Information Systems - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Hospital Information Systems - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Hospital Information Systems - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Hospital Information Systems - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Hospital Information Systems - A Global Update of Market Trends & Opportunities 8Reportlinker Adds EEG/EMG/Brain Function Monitoring - Global Market Trends 2Reportlinker Adds EEG/EMG/Brain Function Monitoring - Global Market Trends 3Reportlinker Adds EEG/EMG/Brain Function Monitoring - Global Market Trends 4Reportlinker Adds EEG/EMG/Brain Function Monitoring - Global Market Trends 5Reportlinker Adds EEG/EMG/Brain Function Monitoring - Global Market Trends 6Reportlinker Adds EEG/EMG/Brain Function Monitoring - Global Market Trends 7Reportlinker Adds EEG/EMG/Brain Function Monitoring - Global Market Trends 8Book by UCR biologist tells story of 100 year quest for elusive malaria vaccine 58462 1Book by UCR biologist tells story of 100 year quest for elusive malaria vaccine 58462 2Book by UCR biologist tells story of 100 year quest for elusive malaria vaccine 58462 3Book by UCR biologist tells story of 100 year quest for elusive malaria vaccine 58462 4Nanotechnology and synthetic biology 3A What does the American public think 3F 10157 1Nanotechnology and synthetic biology 3A What does the American public think 3F 10157 2New blood thinning drug safer than rat poison 10154 1
... 2007 /PRNewswire/ - Cytochroma Inc.,announced tod...CTA018 Injection. The initial top-line results fro...tolerated. Complete study,results are expected in ...l was an open label,placebo-controlled, randomize...lthy volunteers. In this trial, the safety of,CTA0...
...INESS WIRE)--Jun 28, 2007 - CombinatoRx,Incorpora...ults of,its randomized, blinded, placebo-controlle...atoid arthritis (RA). The trial,compared CRx-150 p...) to placebo plus DMARD (control) in subjects with...ial, CRx-150 demonstrated,statistically significan...
Other Medicine Technology:Cytochroma Reports Positive Phase I Clinical Data for CTA018,Injection 2Cytochroma Reports Positive Phase I Clinical Data for CTA018,Injection 3CombinatoRx Product Candidate CRx-150 Shows Activity on DAS28 and,Pain, but Not CRP 2CombinatoRx Product Candidate CRx-150 Shows Activity on DAS28 and,Pain, but Not CRP 3CombinatoRx Product Candidate CRx-150 Shows Activity on DAS28 and,Pain, but Not CRP 4CombinatoRx Product Candidate CRx-150 Shows Activity on DAS28 and,Pain, but Not CRP 5
(Date:12/3/2009)...rom replicating in the livers of primates , , ...w drug to treat hepatitis C has shown promise in a...s a new strategy to prevent the hepatitis C virus ...get the virus itself, the new DNA-based drug targe...s C needs to replicate, the researchers explained....
(Date:12/3/2009)...ec. 3 An exciting treatment gainin...alled platelet-rich plasma therapy (PRP), is showi...tal implant procedures, according to a prominent d...l Implantology . ,, James Rutkowski, DMD, PhD... of the American Academy of Implant Dentistry that...
(Date:12/3/2009)...Deutsches rzteblatt International contains the fi...e with the novel influenza A virus (H1N1/09) in th... pandemic. Ralf Winzer and his coauthors from the ...uated data from a large clinical cohort of infecte...6[47]: 770-6). Their medical-scientific article is...
(Date:12/3/2009)... 450 Deaths a day is still too many - stalled m... Atlanta, GA, Geneva, New Yor...-- The Measles Initiative announced today that mea... 2008, from an estimated 733 000 in 2000 to 164 00...rn of a resurgence in measles deaths if vaccinatio...
(Date:12/3/2009)... Nutra Pharma will be conducting a webinar on D...ver-the-counter and prescription treatments for ch... Plantation, FL (Vocus) December 3, 2...nology company that is developing treatments for A...osis (MS), has announced today that it will be hos...
Breaking Medicine News(10 mins):Health News:New Hepatitis C Treatment Shows Promise 2Health News:New Hepatitis C Treatment Shows Promise 3Health News:Platelet-rich Plasma Enhances Bone and Tissue Growth for Dental Implants 2Health News:Global Measles Deaths Drop By 78%, But Resurgence Likely 2Health News:Global Measles Deaths Drop By 78%, But Resurgence Likely 3Health News:Global Measles Deaths Drop By 78%, But Resurgence Likely 4Health News:Nutra Pharma Announces Upcoming Webinar to Discuss the Company's Over-the-Counter (OTC) and Prescription Treatments for Chronic Pain 2Health News:Nutra Pharma Announces Upcoming Webinar to Discuss the Company's Over-the-Counter (OTC) and Prescription Treatments for Chronic Pain 3
... individuals – are critical to the prevention of c... for the overall health, safety//, and welfare of ...a Commonwealth University physicians published in ...us fluids and medications to patients. There is ri...
...ds that working-age pet owners tend to be more ove... peers.// This is quite controversial to man...p people cope with various physical and psychologi...h.D., and Ansa Ojanlatva, Ph.D., of the University...
...d surgeries make surgeries 'in difficult to access...urgeries for colon cancers are on the rise, while ... common. Colorectal cancer is the third most...sity among the nation's population. More than 140,...
...repeated its plea to doctors over prescription of ...e ?85 millions in the coming year if GPs// prescri...ry Care Trusts (PCTs) can prescribe generic versio...ts. Pravastatin and simvastatin are deemed to be a...
...t the San Francisco's 2002 Gay Pride, San Francisc...d campaign to popularize syphilis testing. I... "Healthy Penis" was introduced to Gayville, encou...ith the Ad and scoffed at the cartoon crusade, hea...
...reaks reported from Vietnam and South Korea has pu...nistry is fully stocked and ready to deal with the... The Ministry has a stock of 2.5 million capsules..., Permanent Secretary for Public Health Prat Boony...
Other Medicine News:Health News:Medical Teams Are Key to Patient Safety 2Health News:Pet Owners Less Healthy: Study Unveils 2Health News:Robotically Assisted Colo-resection And Gastric Bypass Surgeries Are Becoming Popular 2
Reusable Thoracoscopy Cannula
...eatured trocar that consists of a flat bladed tip ...signed to cover the flat bladed tip to protect int...the abdominal or thoracic cavity has been entered.... to enhance trocar sleeve fixation in the patient....
...onsists of a sharp pyramidal blade, and spring-loa...ramidal tip to protect internal structures from pu...c cavity has been entered. Due to reduced force to...red. , ,The single-patient use trocar sleeve hous...
MultAcoice™ Metzenbaum Straight Scissors
Medicine Products: